预后标志-话题@MedSci

#预后标志#

33篇内容 | 1625人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1820008, encodeId=326f1820008ae, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, objectType=article, longId=158432, objectId=5b21158432fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b21158432fa, replyNumber=0, likeNumber=72, createdTime=2019-03-14, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b21158432fa, moduleTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b21158432fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820007, encodeId=d755182000ee6, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, objectType=article, longId=151371, objectId=877a1513e1a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877a1513e1a3, replyNumber=0, likeNumber=110, createdTime=2018-10-28, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877a1513e1a3, moduleTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877a1513e1a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820004, encodeId=ba2e1820004f4, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Eur Heart J：睡眠血压：血管风险的预后标志和预防治疗靶点, objectType=article, longId=146479, objectId=26341464e9e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26341464e9e9, replyNumber=0, likeNumber=104, createdTime=2019-05-01, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26341464e9e9, moduleTitle=Eur Heart J：睡眠血压：血管风险的预后标志和预防治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26341464e9e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820006, encodeId=938f1820006c5, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤, objectType=article, longId=150551, objectId=840e1505514b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=840e1505514b, replyNumber=0, likeNumber=63, createdTime=2019-02-16, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=840e1505514b, moduleTitle=Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=840e1505514b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820005, encodeId=26081820005ed, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物, objectType=article, longId=149622, objectId=7008149622a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7008149622a9, replyNumber=0, likeNumber=87, createdTime=2019-08-07, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7008149622a9, moduleTitle=Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7008149622a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820001, encodeId=82c918200015a, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？, objectType=article, longId=100483, objectId=16fd1004836f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16fd1004836f, replyNumber=0, likeNumber=99, createdTime=2018-01-29, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16fd1004836f, moduleTitle=CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16fd1004836f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820002, encodeId=a3451820002ca, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路, objectType=article, longId=111753, objectId=336d111e5353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336d111e5353, replyNumber=0, likeNumber=79, createdTime=2018-07-25, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336d111e5353, moduleTitle=Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=336d111e5353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820003, encodeId=1d6a182000320, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点, objectType=article, longId=118805, objectId=dfe711880501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfe711880501, replyNumber=0, likeNumber=79, createdTime=2018-04-21, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfe711880501, moduleTitle=Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfe711880501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819999, encodeId=e83b181999950, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物, objectType=article, longId=85442, objectId=04e9854427f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04e9854427f, replyNumber=0, likeNumber=70, createdTime=2017-05-11, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04e9854427f, moduleTitle=Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04e9854427f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1820000, encodeId=ad1a182000099, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物, objectType=article, longId=94233, objectId=67f19423360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67f19423360, replyNumber=0, likeNumber=95, createdTime=2017-04-04, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67f19423360, moduleTitle=HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67f19423360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819998, encodeId=c98918199989d, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, objectType=article, longId=63098, objectId=b602630980d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b602630980d, replyNumber=0, likeNumber=84, createdTime=2016-11-24, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b602630980d, moduleTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b602630980d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819997, encodeId=a10c181999e4d, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者, objectType=article, longId=62483, objectId=1b9762483b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b9762483b8, replyNumber=0, likeNumber=73, createdTime=2016-11-03, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b9762483b8, moduleTitle=NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b9762483b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819996, encodeId=0a9b1819996c3, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=JCO：乳腺密度或可作为接受他莫昔芬治疗的乳腺癌患者预后标志, objectType=article, longId=21048, objectId=a0c5210483b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0c5210483b, replyNumber=0, likeNumber=91, createdTime=2014-01-07, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0c5210483b, moduleTitle=JCO：乳腺密度或可作为接受他莫昔芬治疗的乳腺癌患者预后标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0c5210483b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819995, encodeId=c35a1819995b6, content=<a href='/topic/show?id=0b11100190a4' target=_blank style='color:#2F92EE;'>#预后标志#</a>, objectTitle=Am J Cardiol：营养危险指数为心衰预后标志, objectType=article, longId=4183, objectId=e7c0418397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7c0418397, replyNumber=0, likeNumber=67, createdTime=2012-06-29, rootId=0, userName=xuruicheng, userId=6595338, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7c0418397, moduleTitle=Am J Cardiol：营养危险指数为心衰预后标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7c0418397)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

预后标志

2020-05-29

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关

2019-03-14

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物

2018-10-28

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Eur Heart J：睡眠血压：血管风险的预后标志和预防治疗靶点

2019-05-01

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤

2019-02-16

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物

2019-08-07

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？

2018-01-29

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路

2018-07-25

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点

2018-04-21

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物

2017-05-11

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物

2017-04-04

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

JCO：肿瘤淋巴细胞浸润可以作为预后标志物

2016-11-24

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者

2016-11-03

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

JCO：乳腺密度或可作为接受他莫昔芬治疗的乳腺癌患者预后标志

2014-01-07

xuruicheng (审核中...)

前往app查看评论内容

#预后标志#

Am J Cardiol：营养危险指数为心衰预后标志

2012-06-29

科室
- - 订阅+
  - 更多科室
工具
服务